LifeScience Clinical & Diagnostic

NGeneBio launched NGS based breast cancer diagnostic service in Thailand

Launched NGS based  breast cancer diagnostic service in a newly installed inspection laboratory of a Thai consignment inspection agency, MP Group. &n...

 February 06, 2023 | News

GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Combined with other clinical risk factors the test provides a comprehensive risk assessment in a simple saliva test.   Highlights: New test integ...

 February 03, 2023 | News

Lunit's AI solution is the first application tool that enhance Guardant Health's portfolio of cancer tests

Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC Lunit...

 February 02, 2023 | News

Superstratum and AirAnswers® Team-Up in the Fight Against Sick Building Syndrome

Both companies join forces to identify and alleviate indoor mycotoxins and molds that can contribute to symptoms associated with sick building syndrome. Si...

 February 02, 2023 | News

Lupin Launches LYFE, its Digital Therapeutic Solution for Holistic Heart Care

Designed by leading Indian cardiologists, LYFE helps patients improve their heart health through doctor-connected online and offline modules. FDA and CE ap...

 January 27, 2023 | News

Esaote presents the world premiere of its new MyLab™X90 ultrasound device

Esaote, a leading Italian company in the biomedical sector – in ultrasound, dedicated MRI and medical IT– presents the world premiere of M...

 January 27, 2023 | News

Terumo and Siemens Healthineers India collaborate to strengthen cardiac care in India

Focus on joint Healthcare providers’ training and education initiatives and innovative programs for physicians  First-of-its-kind Cathlab D...

 January 25, 2023 | News

South Australia's health system and The Clinician partner to deliver State-wide Patient Reported Measures Program

South Australia's Commission on Excellence and Innovation in Health (CEIH), South Australia's Department for Health and Wellbeing (SA Health...

 January 25, 2023 | News

Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test

The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolutio...

 January 23, 2023 | News

Genexine Receives Fast Track Designation from Korean Health Authority (MFDS) for its promising DNA vaccine for advanced cervical cancer

Following an evaluation of the full set of Phase 2 data from the recently completed clinical trial in advanced cervical cancer, Korea’s Health Author...

 January 23, 2023 | News

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a further A$3 million secured via an Au...

 January 23, 2023 | News

South Korean diagnostics company NGeneBio is accelerating its expansion into the ASEAN precision diagnosis market.

▶ Securing breast and ovarian cancer precision diagnosis reference through clinical evaluation ▶ Expansion of opportunities to develops global advance...

 January 19, 2023 | News

Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes

Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping Lunit's presentations this year will highligh...

 January 19, 2023 | News

Ascletis Announces Entering into a Supply Agreement of Ritonavir Tablets with Simcere

Ritonavir tablet is a pharmacokinetic booster of multiple oral antiviral protease inhibitors. Ascletis currently owns the only authorized ritonavir oral ta...

 January 17, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close